Demographics (2)
- AGE - Subject age at time of treatment (phv00534838.v1.p1)
- SEX - Biological sex (phv00534832.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for hodgkin lymphoma (phv00534836.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00534844.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00534843.v1.p1)
- COHORT - Cohort subject included in (phv00534837.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00534831.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00534846.v1.p1)
- IS_TUMOR - Tumor status (phv00534845.v1.p1)
- PFS - Progression free survival following treatment (phv00534841.v1.p1)
- PFSEVENT - Presence of progression free survival (PFS) event following treatment (phv00534840.v1.p1)
- SAMPLE_ID - Sample ID (phv00534842.v1.p1)
- SAMPLE_ID - Sample ID (phv00534834.v1.p1)
- STAGE - Disease stage (phv00534839.v1.p1)
- SUBJECT_ID - Subject ID (phv00534835.v1.p1)
- SUBJECT_ID - Subject ID (phv00534830.v1.p1)
- SUBJECT_ID - Subject ID (phv00534833.v1.p1)
- TIMEPOINT - Time point of sample collection; C is the cycle of therapy, and D is the day in each cycle. (phv00534847.v1.p1)
- TYPE - Type of profiling (phv00534848.v1.p1)